stockrowHalozyme Therapeutics, Inc.
HALO Healthcare Biotechnology
Halozyme Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 37.6% from fiscal 2024.
- Revenue
- +39.2%
- EPS
- +45.6%
- Free cash flow
- −58.6%
- Total debt
- +115.1%
Quarter to September 2026, against a year earlier
Follow HALO
Alert me
Halozyme Therapeutics, Inc. (HALO) Operating margin
Halozyme Therapeutics, Inc.'s operating margin over the twelve months to 30 September 2026 was 37.4%, up 3.8 percentage points from fiscal 2025 (33.6%). Over the past ten years it has ranged from −56.7% (fiscal 2016) to 62.2% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 33.6% | (20.74) |
| FY2024 | 54.3% | 13.61 |
| FY2023 | 40.7% | 0.18 |
| FY2022 | 40.5% | (21.71) |
| FY2021 | 62.2% | 8.33 |
| FY2020 | 53.9% | 88.41 |
| FY2019 | −34.5% | 11.15 |
| FY2018 | −45.7% | (71.23) |
| FY2017 | 25.6% | 82.30 |
| FY2016 | −56.7% | (36.39) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 59.8% | 0.03 |
| Jun 2026 | 59.8% | 10.82 |
| Mar 2026 | 49.0% | 69.54 |
| Dec 2025 | −20.6% | (82.07) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| EXEL Exelixis, Inc. compare | 40.2% |
| HALO Halozyme Therapeutics, Inc. | 37.4% |
| ASND Ascendis Pharma A/S compare | 24.8% |
| TECH Bio-Techne Corp compare | 20.7% |
| JAZZ Jazz Pharmaceuticals PLC compare | 9.03% |
| BMRN BioMarin Pharmaceutical Inc. compare | 3.12% |
| SMMT Summit Therapeutics PLC compare | 0.00% |
| KYMR Kymera Therapeutics, Inc. compare | 0.00% |
| BBIO BridgeBio Pharma, Inc. compare | −38.5% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on HALO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement